The novel approach of the medication represents a significant breakthrough in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP https://tirzepatidepeptide690738.educationalimpactblog.com/63597910/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment